Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Raynaud's phenomenon: a proposal for classification.

E C LeRoy1, T A Medsger

  • 1Department of Medicine, Medical University of South Carolina, Charleston 29425-2229.

Clinical and Experimental Rheumatology
|September 11, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Scandinavian journal of rheumatology·2017
Same author

Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients.

Clinical and experimental rheumatology·2014
Same author

Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.

The Journal of steroid biochemistry and molecular biology·2010
Same author

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.

Annals of the rheumatic diseases·2006
Same author

The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.

Clinical and experimental rheumatology·2004
Same author

The Lupus Foundation as an additional source for case ascertainment: developing a community-based lupus registry.

Arthritis care and research : the official journal of the Arthritis Health Professions Association·2003
Same journal

The expanded cardiovascular risk prediction score as a cardiovascular mortality predictor in rheumatoid arthritis.

Clinical and experimental rheumatology·2026
Same journal

Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

Clinical and experimental rheumatology·2026
Same journal

Clinical features and gastrointestinal bleeding risk factors in IgA vasculitis patients: a retrospective study in a large volume centre.

Clinical and experimental rheumatology·2026
Same journal

Reply to the comment on: The microbiota in axial spondyloarthritis: what have we learned from Mendelian randomisation studies?

Clinical and experimental rheumatology·2026
Same journal

Comprehensive evaluation of bone structural and microarchitectural changes in rheumatoid arthritis treated with baricitinib using HR-pQCT, imaging, and biomarker analyses.

Clinical and experimental rheumatology·2026
Same journal

Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy.

Clinical and experimental rheumatology·2026
See all related articles

Defining Primary Raynaud's Phenomenon (PRP) remains challenging due to inconsistent classifications. This study proposes strict criteria for PRP, successfully classifying 89% of patients in a retrospective analysis.

Area of Science:

  • Vascular Medicine
  • Rheumatology
  • Clinical Diagnostics

Background:

  • Inconsistent definitions of Primary Raynaud's Phenomenon (PRP) and secondary Raynaud's phenomenon cause diagnostic confusion.
  • Variations in classification criteria lead to the same patient being categorized differently by various medical groups.
  • A clear, standardized definition for PRP is needed to improve diagnostic accuracy and patient management.

Purpose of the Study:

  • To propose a strict, hypothesis-driven definition for Primary Raynaud's Phenomenon (PRP).
  • To establish criteria amenable to experimental testing for classifying PRP.
  • To retrospectively evaluate the efficacy of the proposed definition in a patient cohort.

Main Methods:

  • Formulation of a hypothesis for a strict definition of Primary Raynaud's Phenomenon (PRP).

Related Experiment Videos

  • Retrospective analysis of 240 patients diagnosed with Raynaud's phenomenon.
  • Application of the proposed criteria to classify patients into primary or secondary categories.

    • Main Results:

    • The proposed criteria allowed for classification in 215 out of 240 patients (89%).
    • A subset of 25 patients (11%) remained difficult to classify using the initial evaluation.
    • The hypothesis demonstrated significant utility in standardizing PRP classification.

    Conclusions:

    • The proposed strict definition for Primary Raynaud's Phenomenon (PRP) offers a more consistent approach to classification.
    • Further research and testing are encouraged to refine and validate these diagnostic criteria.
    • Improved diagnostic clarity for PRP can enhance clinical research and patient care.